Ixazomib (MLN9708) in Combination With Carboplatin in Pretreated Women With Advanced Triple Negative Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Triple-Negative Breast Cancer
Interventions: DRUG: Ixazomib|DRUG: Carboplatin
Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie
Collaborators: Takeda